Unfortunately,
experts say that these tariffs will likely raise expenses for patients, disrupt global supply chains, and create drug shortages. “The reality is that patients feel the pain of tariffs long before any potential benefits materialize,” says Merith Basey, the executive director of
Patients for Affordable Drugs. “And history shows that drugmakers will simply pass the added costs onto them.”
